-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EOdJlSLQfH0bbBwKv1/D78zNefRjyTuyiueLpb1SygyBIKsJkDa9qY3F3G4rtJtB WJTyHWynqVV6NEPxfNVfzg== 0001307826-09-000009.txt : 20090821 0001307826-09-000009.hdr.sgml : 20090821 20090821163904 ACCESSION NUMBER: 0001307826-09-000009 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090821 DATE AS OF CHANGE: 20090821 EFFECTIVENESS DATE: 20090821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gloucester Pharmaceuticals Inc CENTRAL INDEX KEY: 0001307826 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-70770 FILM NUMBER: 091028986 BUSINESS ADDRESS: STREET 1: 1 BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-583-1300 MAIL ADDRESS: STREET 1: 1 BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0502 D LIVE 0001307826 Gloucester Pharmaceuticals Inc 1 BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-583-1300 None DELAWARE Corporation true Jean C. Nichols One Broadway 14th Floor Cambridge MA 02142 Executive Officer Alan B. Colowick One Broadway 14th Floor Cambridge MA 02142 Executive Officer Director Nicholas Vrolijk One Broadway 14th Floor Cambridge MA 02142 Executive Officer Martin Vogelbaum One Broadway 14th Floor Cambridge MA 02142 Director David Schnell One Broadway 14th Floor Cambridge MA 02142 Director Jay Moorin One Broadway 14th Floor Cambridge MA 02142 Director Seth Harrison One Broadway 14th Floor Cambridge MA 02142 Director Donald J. Hayden One Broadway 14th Floor Cambridge MA 02142 Executive Officer Director Thomas Dyrberg One Broadway 14th Floor Cambridge MA 02142 Director Biotechnology Decline to Disclose 06 false 2009-08-14 false true false 0 28881642 20324914 8556728 Total amount sold includes approximately $8.9 million worth of equity issued from converted bridge debt. false 9 0 0 0 false Gloucester Pharmaceuticals Inc /s/ Jean C. Nichols Jean C. Nichols President and Chief Operating Officer 2009-08-21 -----END PRIVACY-ENHANCED MESSAGE-----